Compare Futu Holdings Ltd (FUTU) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Futu Holdings Ltd vs State Street SPDR S&P Biotech ETF — how do they compare? Futu Holdings Ltd trades at $105.88 (market cap $14.74B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: Futu Holdings Ltd pays a 2.47% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Futu Holdings Ltd nearer its low. Which is the better fit depends on your goals.
| FUTU | XBI | |
|---|---|---|
Market Cap | $14.74B | — |
Sector | Financials | Broad Market / Factor |
52-Week High | $199.04 | $164.28 |
52-Week Low | $89.76 | $86.92 |
Enterprise Value | $14.59B | — |
Dividend Yield | 2.47% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Futu Holdings Ltd
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
Read more on FUTU →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
